Replies to post #685208 on NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

I don’t agree with Senti that marketing approval for DCVax-l is now awaiting Eden approval.

I don’t believe I ever wrote anything like that… all I’d indicated (or intended to communicate) in my post to bear trap was that with how long this entire application process has taken, and with some of her call outs in the recent Flaskworks PR, the eden system could be ready to implement very close to an MHRA MAA approval. Nothing more.

[hyperopia]

flipper, I don’t think senti was really saying “that marketing approval for DCVax-l is now awaiting Eden approval,” or I wouldn’t have agreed.

I’m also not suggesting that “the NICE reimbursement process is not currently running parallel.”
I’m suggesting that all three timelines are running in parallel. I should rephrase that part about all timelines being independent though, as of course the NICE reimbursement is tied to the marketing approval.

As I’m re-reading this, I’m also not suggesting just about everything else in your response. You’re just putting words in my mouth, so I’ll just leave it there.